Yes, this is both an excellent illustration of the perils of double counting and the perils of overconfidence in behavioral interventions. The list of indications is over-broad & misrepresented; the practical utility of monitoring (ie. will it work as intended) is overestimated.
-
-
No citation or clinical experience, no argument.pic.twitter.com/9CYSDG0LWs
2 replies 0 retweets 0 likes -
Replying to @DoctorTro @ikitorp and
This isn’t a swans ganz, this is the 6th vitals sign blood sugar. Harm is negligible and information is valuable of a clinician knows how to use and prescribe (unlike the present company )
1 reply 0 retweets 0 likes -
I believe it's generally desirable for a clinician to be capable of reading, and refer you back to the article that is the subject of the present discussion, where it's implied that almost anybody will benefit from dabbling in CGM—not just judicious clinicians and their PATIENTS.pic.twitter.com/bttzKgIMve
1 reply 0 retweets 1 like -
I believe the present clinician may be unaware that nearly 50-60% are prediabetic or diabetic nearly 60% are overweight or obese and almost 90% have at least one criteria for metS. “Almost anybody” It’s sad when clinicians don’t read the literature
1 reply 0 retweets 0 likes -
100% of med students fulfill at least one criteria of at least one psychiatric disorder during their psych rotation. The figures for the remaining categories overlap in the literature, and primarily refer to adults rather than the population as a whole.
1 reply 0 retweets 1 like -
That’s so cool bro.
1 reply 0 retweets 0 likes -
Nah mate, there's nothing cool about you making bombastic claims unsupported by evidence.
1 reply 0 retweets 1 like -
This conversation is a joke. You have not presented a case for harm against published evidence of benefit & clinical expertise Especially considering prediabetes, diabetes, GDM all have indication for gylcemic mentoring anyway the case for harm is even more bizarre
2 replies 0 retweets 0 likes -
Sorry, just to be clear: your primary argument for the use of CGM beyond T2DM is "clinical experience"?
-
-
I believe sufficient evidence exists consider use in prediabetes and gdm. Based on my clinical experience would add in weight mananbent in overweight and obese, reactive hypoglycemia, hyperinsulinemia...
2 replies 0 retweets 0 likes -
But you didn't provide any of that evidence when I asked... That being said, sounds like you're practicing eminence-based medicine. Might want to have a look at some of the articles on why that isn't usually a good choice
1 reply 0 retweets 1 like - Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.